Coronary Artery Bypass Graft Market Outlook:
Coronary Artery Bypass Graft Market size was over USD 13.73 billion in 2024 and is poised to exceed USD 31.33 billion by 2034, growing at over 8.6% CAGR during the forecast period i.e., between 2025-2034. In the year 2025, the industry size of coronary artery bypass graft is evaluated at USD 14.73 billion.
Key Coronary Artery Bypass Graft Market Insights Summary
North America industry is projected to capture the highest revenue share of 49.8% by 2037, dominating the coronary artery bypass graft market.
Asia Pacific is expected to witness the most rapid revenue growth by 2037.
off-pump segment is forecasted to command approximately 56.2% of the coronary artery bypass graft market share by the close of 2037.
single CABG surgery segment is anticipated to account for over 35% of the coronary artery bypass graft market share.
Key Growth Drivers:
- Technological advancements
- Growing healthcare infrastructure
- Awareness and early diagnosis
Key Players:
Medtronic, plc, Guidant Group, Xeltis BV,MAQUET Holding B.V. & Co. KG, Novadaq Technologies Inc., KARL STORZ GmbH & Co. KG, Edwards Lifesciences Corporation, Genesee Biomedical Inc., Sorin Group, Kimal PLC
Market Size and Growth Projections
- 2024 Market Size: USD 13.73 billion
- 2025 Market Size: USD 14.73 billion
- Projected Market Size: USD 31.33 billion by 2034
- Growth Forecasts: 8.6% CAGR (2025-2034)
- Largest Region: North America (49.8% Share by 2034)
- Fastest Growing Region: North America
The primary growth driver of the coronary artery bypass graft market is the rising prevalence of cardiovascular diseases (CVDs) particularly coronary artery disease (CAD). According to the British Heart Foundation, as of 2021, over 250 million people in the world were living with coronary heart disease.
Unhealthy lifestyles, poor dietary habits, smoking, and sedentary behavior have led to a surge in CAD cases, necessitating surgical interventions like coronary artery bypass surgery. Additionally, the growing global elderly population is at higher risk of heart disease, driving demand for CABG procedures. One in six individuals worldwide will be 60 or older by 2030. At this point, there will be 1.4 billion people over 60, up from 1 billion in 2020. The number of individuals in the world who are 60 years of age or older is expected to increase to 2.1 billion by 2050. Between 2020 and 2050, the population of people 80 years of age or older is predicted to triple, reaching 426 million.
Coronary Artery Bypass Graft Market Growth Drivers and Challenges:
Growth Drivers
-
Technological advancements: Technological advancements like the Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) reduce the need for large incisions, resulting in faster recovery, less pain, and lower risk of infection. Endoscopic Vessel Harvesting (EVH), a technique to harvest grafts with minimal tissue damage, improves cosmetic outcomes and reduces recovery time.
Moreover, innovations such as robotic-assisted CABG allow for precise, minimally invasive procedures with smaller incisions, reduced trauma, and faster recovery times. Systems like the da Vinci Surgical System are increasingly used for CABG. For instance, as of the end of 2021, over 6730 da Vinci surgical systems have been installed in 69 countries across the world, with more than 10 million minimally invasive robotic surgical procedures completed, including more than 1.5 million in 2021. -
Growing healthcare infrastructure: The development of specialized cardiac centers and the expansion of hospital networks in developing regions enable more patients to access CABG procedures. Further, modern hospitals and surgical facilities are integrating cutting-edge technologies such as robotic-assisted CABG and advanced imaging systems. These facilities make complex procedures safer and more efficient, increasing patient trust in undergoing CABG surgeries.
Furthermore, governments and private entities in countries like India and China are heavily investing in healthcare infrastructure. For instance, according to a 2021 report on Investment Opportunities in India’s Healthcare Sector published by the NITI Aayog, over the past 20 years, India has become one of the fastest-growing emerging economies, with foreign direct investment (FDI) increasing from USD 2.5 billion in 2000-01 to USD 50 billion in 2019-20. Investors have shown increased interest in the healthcare sector in recent years, with transaction values rising from USD 94 million (2011) to USD 1,275 million (2016), a more than 13.5-fold increase. -
Awareness and early diagnosis: Public health campaigns by organizations like the World Heart Federation and American Heart Association emphasize the risks of coronary artery disease and the importance of early intervention. The World Heart Federation's World Heart Day campaign reached 1.9 million people worldwide. Increased awareness prompts patients to seek timely medical advice, leading to more diagnosis and treatment options, including CABG.
Awareness initiatives stress the importance of addressing risk factors such as hypertension, high cholesterol, and diabetes. Early diagnosis through routine check-ups and health screenings reduces emergency cases and promotes elective CABG surgeries associated with better outcomes. Governments and NGOs in developing countries also fund awareness campaigns to combat rising CVD cases.
Challenges
-
High cost of procedures: CABG surgeries are among the most costly cardiac interventions. Innovations such as robotic-assisted surgeries, minimally invasive techniques, and advanced graft materials come at a premium, increasing the overall cost of CABG. While these technologies improve outcomes, they are not affordable for all patients. Moreover, insurance coverage for major surgical procedures like CABG is minimal or non-existent in many developing countries. This forces patients to bear out-of-pocket expenses, reducing the procedure’s accessibility.
-
Long and complex approval processes: Regulatory agencies like the Food and Drug Administration (FDA) and European Medicines Agency (EMA) require extensive clinical trials and safety evaluations for new graft materials, devices, and surgical techniques. These lengthy processes delay the introduction of advanced products to the market. also, variability in regulatory requirements between regions, such as Europe, and Asia Pacific, creates challenges for manufacturers aiming for global coronary artery bypass graft market entry.
Coronary Artery Bypass Graft Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2034 |
|
CAGR |
8.6% |
|
Base Year Market Size (2024) |
USD 13.73 billion |
|
Forecast Year Market Size (2034) |
USD 31.33 billion |
|
Regional Scope |
|
Coronary Artery Bypass Graft Market Segmentation:
Method Segment Analysis
By method, the off-pump segment is estimated to dominate around 56.2% coronary artery bypass graft market share by the end of 2034. The market growth can be attributed to off-pump CABG’s reduced complications, faster recovery, and advancements in surgical technology. Off-pump CABG also known as beating heart surgery involves performing the bypass surgery without stopping the heart, unlike traditional on-pump CABG, which uses a heart-lung machine. This technique reduces the risk of complications such as stroke, heart attack, and kidney failure.
The growing availability of specialized instruments and technology to assist in off-pump surgeries has made this method more viable and efficient. Enhanced surgical tools like stabilizers, robotic-assisted technologies, and advanced imaging systems have further boosted its adoption. According to a 2023 report published by the National Library of Medicine, the popularity of off-pump coronary artery bypass grafting (CABG) varies around the world, ranging from 20% in Europe and the U.S. to 56% in Asia.
Surgical Procedure Segment Analysis
By 2034, single CABG surgery segment is projected to hold more than 35% coronary artery bypass graft market share. Single-vessel coronary artery disease is common, especially among patients with early stages of coronary artery disease. Single CABG surgery, which involves bypassing a single blocked artery, is often sufficient for these patients. As CAD remains one of the leading causes of morbidity globally, single CABG procedures are in high demand.
Moreover, single CABG surgery is less complex compared to multiple bypass surgeries, making, it more cost-effective. It typically involves fewer risks, shorter operation times, and quicker recovery, all of which are important factors for patients and healthcare providers seeking efficient and affordable treatment options.
Our in-depth analysis of the global coronary artery bypass graft market includes the following segments:
|
Method |
|
|
Surgical Procedure |
|
|
End use |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportCoronary Artery Bypass Graft Market Regional Analysis:
North America Market Insights
North America industry is estimated to hold largest revenue share of 49.8% by 2037. The market growth is attributed to the rising prevalence of cardiovascular diseases, particularly CAD. In addition to the rising disease burden, the region benefits from advanced healthcare infrastructure, cutting-edge medical technologies, and a strong reimbursement system that makes CABG surgeries more accessible.
In the U.S., CVD remains the leading cause of death, which is contributing to the rise of CABG surgeries. For instance, according to the Centers for Disease Control and Prevention (CDC) in 2022, approximately 1 in every 5 deaths from cardiovascular diseases (CVDs) occurred among persons under the age of 65. Furthermore, an aging population, lifestyle factors such as obesity and sedentary behavior, and an increase in associated comorbidities like diabetes are all accelerating the demand for cardiac interventions.
Canada boosts a well-developed healthcare system with significant investments in hospitals and specialized cardiac care centers. This infrastructure supports a high volume of CABG surgeries, particularly in larger hospitals equipped with advanced surgical tools and technologies.
APAC Market Insights
The coronary artery bypass graft market of Asia Pacific is poised to register the fastest revenue growth by 2034. APAC countries are investing heavily in healthcare improvements, expanding the reach of advanced treatment options, including CABG, especially in urban areas. This development is particularly notable in emerging coronary artery bypass graft markets like India and China.
In China, the government is actively investing in the healthcare sector, aiming to improve access to quality medical services. This includes providing better healthcare financing, insurance coverage, and reimbursement for surgeries like CABG, which makes these treatments more accessible to the broader population. China's National Health and Family Planning Commission intends to increase the size of the country's health service sector to approximately USD 2.4 trillion by 2030.
In India, the growing geriatric population is a significant factor, as older individuals are at a higher risk for CADs. This demographic shift is expected to continue fueling demand for CABG procedures in the coming years. According to the United Nations Population Fund (UNFPA), as of 2023, the elderly population in the country reached 153 million and is expected to reach 347 million by 2050.
Key Coronary Artery Bypass Graft Market Players:
- Medtronic, plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Guidant Group
- Xeltis BV
- MAQUET Holding B.V. & Co.KG
- Novadaq Technologies Inc.
- KARL STORZ GmbH & Co. KG
- Edwards Lifesciences Corporation
- Genesee Biomedical Inc.
- Sorin Group
- Kimal PLC
Key players in the coronary artery bypass graft market are contributing through innovations in surgical techniques, technology, and healthcare solutions. Investments and partnerships among government and private sectors are improving the quality and accessibility of CABG procedures and are also contributing to the overall growth of the market by making the surgeries more efficient across diverse regions.
Here are some key players in the coronary artery bypass graft market:
Recent Developments
- In February 2023, Xeltis, a medical technology firm situated in Eindhoven, the Netherlands, raised USD 33.65 million in a Series D2 equity funding round. The company is pioneering a restorative approach to heart valve replacement and vascular therapy, based in part on research conducted at Eindhoven University of Technology.
- In February 2023, Kimal PLC announced a new strategic partnership with Marizyme, Inc. for DuraGraft, the company's flagship product. This collaboration will combine Marizyme's expertise in creating novel medical device technology with Kimal's broad distribution network and specialized market understanding. Together, the companies will bring DuraGraft to market more efficiently and effectively, resulting in a larger network of healthcare practitioners and patients who can benefit from DuraGraft during CABG surgeries.
Author Credits: Radhika Pawar
- Report ID: 732
- Published Date: Jun 13, 2025
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Coronary Artery Bypass Graft Market Report Scope
Copyright @ 2025 Research Nester. All Rights Reserved.
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
See our insights in action - schedule your demo now!